- Home
- HOTH vs CYCU Comparison
HOTH vs CYCU Comparison
Compare HOTH & CYCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOTH
- CYCU
- Stock Information
- Founded
- HOTH 2017
- CYCU N/A
- Country
- HOTH United States
- CYCU United States
- Employees
- HOTH N/A
- CYCU N/A
- Industry
- HOTH Biotechnology: Pharmaceutical Preparations
- CYCU
- Sector
- HOTH Health Care
- CYCU
- Exchange
- HOTH Nasdaq
- CYCU Nasdaq
- Market Cap
- HOTH 15.6M
- CYCU 13.1M
- IPO Year
- HOTH 2019
- CYCU N/A
- Fundamental
- Price
- HOTH $1.31
- CYCU $0.35
- Analyst Decision
- HOTH Strong Buy
- CYCU
- Analyst Count
- HOTH 3
- CYCU 0
- Target Price
- HOTH $4.00
- CYCU N/A
- AVG Volume (30 Days)
- HOTH 426.2K
- CYCU 3.1M
- Earning Date
- HOTH 05-12-2025
- CYCU 08-15-2025
- Dividend Yield
- HOTH N/A
- CYCU N/A
- EPS Growth
- HOTH N/A
- CYCU N/A
- EPS
- HOTH N/A
- CYCU N/A
- Revenue
- HOTH N/A
- CYCU $17,398,680.00
- Revenue This Year
- HOTH N/A
- CYCU N/A
- Revenue Next Year
- HOTH N/A
- CYCU N/A
- P/E Ratio
- HOTH N/A
- CYCU N/A
- Revenue Growth
- HOTH N/A
- CYCU N/A
- 52 Week Low
- HOTH $0.58
- CYCU $0.26
- 52 Week High
- HOTH $3.80
- CYCU $10.99
- Technical
- Relative Strength Index (RSI)
- HOTH 51.27
- CYCU N/A
- Support Level
- HOTH $1.21
- CYCU N/A
- Resistance Level
- HOTH $1.41
- CYCU N/A
- Average True Range (ATR)
- HOTH 0.10
- CYCU 0.00
- MACD
- HOTH -0.01
- CYCU 0.00
- Stochastic Oscillator
- HOTH 41.30
- CYCU 0.00
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).
About CYCU Cycurion Inc. Common Stock
Cycurion Inc. provides information technology security solutions through its subsidiaries. The Company continually strives to deliver top-notch services in risk management, cybersecurity, information assurance, systems engineering, and help desk solutions. The company generates the majority of its revenue from Advisory Consulting services, with small portion revenue generated from Managed Security Service Practice (MSSP) and Software as a Service (Saas).